Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

NEXT STORY
Predictmedix and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide
PREV STORY
electroCore, Inc. Announces Regulatory Approval in Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that ...

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Bladder Cancer at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

RX-3117 Monotherapy Increased Progression Free Survival and Showed Evidence of Tumor Shrinkage in Patients ...

author_avatar
NASDAQ Market News

Brii Biosciences, Vir Biotechnology and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B

author_avatar
NASDAQ Market News